Live Quote · NASDAQTLPHHealthcare· Drug Manufacturers - Specialty & Generic

Talphera, Inc.

$1.07 1.90%(+$0.02)
TickerSpark Score
60/100
Mixed
40
Valuation
40
Profitability
60
Growth
80
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TLPH research report →

52-Week Range58% of range
Low
$0.38
Current
$1.07
High
$1.57
Company Overviewtalphera.com

About the company

Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat.

CEO
Vincent J. Angotti
IPO
2011
Employees
13
HQ
San Mateo, CA, US

Price Chart

+137.25% · this period
$1.46$0.93$0.39Jul 02Dec 31Jul 02
Valuation
Market Cap
$21.95M
P/E
-2.98
P/S
21952.78
P/B
2.46
EV/EBITDA
-1.27
Div Yield
0.00%
Profitability
Gross Margin
100.00%
Op Margin
-1451600.00%
Net Margin
-1425300.00%
ROE
-92.98%
ROIC
-55.55%
Growth & Income
Revenue
$28.00K · 0.00%
Net Income
$-14,290,000 · -9.89%
EPS
$-0.34 · 32.00%
Op Income
$-13,484,000
FCF YoY
10.40%
Performance & Tape
52W High
$1.57
52W Low
$0.38
50D MA
$0.88
200D MA
$0.99
Beta
0.76
Avg Volume
184.35K

Get TickerSpark's AI analysis on TLPH

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 22, 26WAN MARK Aother30,700
Jun 22, 26WAN MARK Aother5,100
Jun 22, 26Todisco Josephother30,700
Jun 22, 26Todisco Josephother5,100
Jun 22, 26JAIN ABHINAVother30,700
Jun 22, 26JAIN ABHINAVother5,100
Jun 22, 26HOFFMAN STEPHEN Jother30,700
Jun 22, 26HOFFMAN STEPHEN Jother5,100
Jun 22, 26Broadfoot Jill Marieother30,700
Jun 22, 26Broadfoot Jill Marieother5,100
Coverage · TLPH

Our TLPH coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on TLPH yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate TLPH report →
Internal Compare

Similar companies

Peers in the same neighborhood.